Maryland Oncology Hematology — Annapolis, Maryland

Maryland Oncology Hematology is a clinical research site located in Annapolis, Maryland, United States 21401.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Maryland Oncology Hematology has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: SARS-CoV-2 Infection, Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Sponsors: MediMergent, LLC, Greenwich LifeSciences, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Maryland Oncology Hematology?

Maryland Oncology Hematology has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Maryland Oncology Hematology conducted?

Maryland Oncology Hematology has 5 clinical trials on record, with 3 currently active. Their work covers SARS-CoV-2 Infection, Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Is Maryland Oncology Hematology accredited by Crixeo Health?

Maryland Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Maryland Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.